At a glance
- Originator Nonindustrial source
- Class Antiplatelets; Ischaemic heart disorder therapies; Small molecules; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Coronary thrombosis; Thrombosis